218 related articles for article (PubMed ID: 1546516)
21. The cytologic application of carcinoembryonic antigen for the discrimination of malignant from benign serous effusions.
Kyrkou KA; Iatridis SG; Athanassiadou PP; Athanassiadis PP; Mandragos CE
Cancer Detect Prev; 1985; 8(1-2):247-54. PubMed ID: 4064045
[TBL] [Abstract][Full Text] [Related]
22. Cytological study of serous effusions with the aid of tumour markers.
Ray K; Mittal S; Gupta H; Jain M
J Indian Med Assoc; 1999 Jan; 97(1):11-2, 19. PubMed ID: 10549179
[TBL] [Abstract][Full Text] [Related]
23. [Differential cytology of effusions using monoclonal antibodies].
Lüttges J; Neumann K; Pflüger KH; Schmitz-Moormann P
Pathologe; 1988 May; 9(3):137-42. PubMed ID: 2457213
[No Abstract] [Full Text] [Related]
24. The correlation of routine cytology with the contents of carcinoembryonic antigen and alpha-fetoprotein in pleural and peritoneal effusions.
Breborowicz D; Majewski P; Simon I; Gladysz K; Breborowicz J
Arch Geschwulstforsch; 1977; 47(3):231-5. PubMed ID: 71884
[TBL] [Abstract][Full Text] [Related]
25. Value of immunocytochemistry in the study of malignant effusions.
Mason MR; Bedrossian CW; Fahey CA
Diagn Cytopathol; 1987 Sep; 3(3):215-21. PubMed ID: 3311665
[TBL] [Abstract][Full Text] [Related]
26. Immunohistochemical panel for distinguishing between carcinoma and reactive mesothelial cells in serious effusions.
Lee JS; Nam JH; Lee MC; Park CS; Juhng SW
Acta Cytol; 1996; 40(4):631-6. PubMed ID: 8693877
[TBL] [Abstract][Full Text] [Related]
27. [Diagnostic value of carcinoembryonic antigen (CEA) concentration in malignant pleural and ascitic fluids - in comparison with cytodiagnosis (author's transl)].
Makino M; Matsui H; Kato S; Koshimizu M; Kimura M
Rinsho Byori; 1981; 29(7):736-40. PubMed ID: 7328807
[No Abstract] [Full Text] [Related]
28. Use of a panel of markers in the differential diagnosis of adenocarcinoma and reactive mesothelial cells in fluid cytology.
Ko EC; Jhala NC; Shultz JJ; Chhieng DC
Am J Clin Pathol; 2001 Nov; 116(5):709-15. PubMed ID: 11710688
[TBL] [Abstract][Full Text] [Related]
29. Malignant mesothelioma: immunohistochemistry and DNA ploidy analysis as methods to differentiate mesothelioma from benign reactive mesothelial cell proliferation and adenocarcinoma in pleural and peritoneal effusions.
Friedman MT; Gentile P; Tarectecan A; Fuchs A
Arch Pathol Lab Med; 1996 Oct; 120(10):959-66. PubMed ID: 12046609
[TBL] [Abstract][Full Text] [Related]
30. Diagnostic value of three tumor markers determined in pleural effusions.
Conejo JR; Benedito JE; Jimenez A; Menchen M; Cano J; Granizo V; Larrodera L
Eur J Clin Chem Clin Biochem; 1996 Feb; 34(2):139-42. PubMed ID: 8833646
[TBL] [Abstract][Full Text] [Related]
31. Diagnostic significance of cancer antigen 125, pancreatic oncofetal antigen, and carcinoembryonic antigen in malignant and tuberculous pleural effusions.
Niwa Y; Shimokata K
Jpn J Clin Oncol; 1986 Mar; 16(1):3-8. PubMed ID: 3009919
[TBL] [Abstract][Full Text] [Related]
32. Malignant ascites of serous papillary ovarian adenocarcinoma. An immunocytochemical study of the tumor cells.
Guzman J; Hilgarth M; Bross KJ; Ross A; Wiehle U; Kresin V; Grunert F; von Kleist S
Acta Cytol; 1988; 32(4):519-22. PubMed ID: 3041721
[TBL] [Abstract][Full Text] [Related]
33. Comparison of serum assays for TAG-72, CA19-9 and CEA in gastrointestinal carcinoma patients.
Ohuchi N; Takahashi K; Matoba N; Sato T; Taira Y; Sakai N; Masuda M; Mori S
Jpn J Clin Oncol; 1989 Sep; 19(3):242-8. PubMed ID: 2810823
[TBL] [Abstract][Full Text] [Related]
34. [The role of epithelial antigens in diagnosis and staging of breast cancer].
Artamonova EV; Tupitsyn NN; Kadagidze ZG; Letiagin VP; Ermilova VD; Ognerubov NA; Panichenko AV; Riazantseva SN
Arkh Patol; 2002; 64(6):13-5. PubMed ID: 12534220
[TBL] [Abstract][Full Text] [Related]
35. [Gallbladder cancer: immunohistochemical expression of CA-19-9, epithelial membrane antigen, dupan-2 and carcinoembryonic antigen].
Roa I; Araya JC; Shiraisch T; Yatani R; Wistuba I; Villaseca M; de Aretxabala X
Rev Med Chil; 1992 Nov; 120(11):1218-26. PubMed ID: 1340939
[TBL] [Abstract][Full Text] [Related]
36. [High Ca 125 serum level in benign ascites or pleural effusion].
Mezger J; Häussinger KE; Wilmanns W; Lamerz R
Geburtshilfe Frauenheilkd; 1987 Jul; 47(7):463-5. PubMed ID: 3476336
[TBL] [Abstract][Full Text] [Related]
37. Diagnostic value of carcinoembryonic antigen assay of pleural & peritoneal effusions in malignancy.
Gandhi AK; Nayar M; Bihari N; Chandra M
Indian J Med Res; 1989 Feb; 90():22-6. PubMed ID: 2722212
[TBL] [Abstract][Full Text] [Related]
38. Immunofluorescent staining of metastatic carcinoma cells in serious fluid with carcinoembryonic antibody, epithelial membrane antibody, AUA-1 and Ber-EP4.
Illingworth AL; Young JA; Johnson GD
Cytopathology; 1994 Oct; 5(5):270-81. PubMed ID: 7819512
[TBL] [Abstract][Full Text] [Related]
39. Value of BCA-225 in the cytologic diagnosis of malignant effusions: an immunocytochemical study of 197 cases.
Loy TS; Diaz-Arias AA; Bickel JT
Mod Pathol; 1990 May; 3(3):294-7. PubMed ID: 2194212
[TBL] [Abstract][Full Text] [Related]
40. Immunocytochemical panel for distinguishing carcinoma cells from reactive mesothelial cells in pleural effusions.
Wu GP; Zhang SS; Fang CQ; Liu SL; Wang EH
Cytopathology; 2008 Aug; 19(4):212-7. PubMed ID: 18699986
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]